Compare Aurora Cannabis Inc (ACB) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

TLT, the iShares 20+ Year Treasury Bond ETF, trades at $84.55, down 1.12% on the day, reflecting ongoing bearish pressure in the long-duration Treasury market. Technical indicators are predominantly bearish, with moving averages signaling a strong sell, while oscillators remain neutral. The fund has faced significant drawdowns recently, losing nearly 48% since 2020, but now offers higher starting yields, attracting investor attention amid shifting Fed policy expectations and inflation concerns.

The outlook for TLT hinges on Federal Reserve interest rate decisions and inflation trends. Opportunities exist for yield-seeking investors due to elevated distributions, but risks include potential further rate hikes, prolonged high inflation, and interest rate sensitivity. Market sentiment is mixed, with some analysts seeing value after the steep decline, while others caution about duration risk in a volatile macroeconomic environment.